RemeGen Lands $5.6 Bn Deal – Why Bispecific Antibody Technology Keeps Drawing Multinational Giants 2026-01-13 2026-01-13 Sign In To Get Full Access. On-the-ground China market intelligence for professionals. Beyond mainstream headlines, cutting through algorithmic noise. Start Free Now >>>
